Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3‐year‐old boy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.15353
Abstract: mRNA vaccine (Pfizer/BioNTech or Moderna). There were no nonresponders (antibody titres below the cut-off); however, the patient group had significantly lower levels of IgG against SARS-CoV-2 (mean SD 2053 1218 BAU/mL, range 98.2–3840 BAU/mL) compared… read more here.
Keywords: successful treatment; severe pityriasis; treatment severe; treatment ... See more keywords